D. E. Shaw & Co., Inc. Insmed Inc Put Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $620,000 - $790,100	10,000 New	10,000 $730,000
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $522,000 - $841,500	45,000 New	45,000 $590,000

465

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.